# FDA Inspection 1202361 - Gundersen Clinic Ltd, IRB #1 - April 06, 2023

Source: https://www.keypedia.com/records/fda_inspections/gundersen-clinic-ltd-irb-1/3e945979-21fc-48fe-afe5-efa04cdb9dd1
Source feed: FDA_Inspections

> FDA Inspection 1202361 for Gundersen Clinic Ltd, IRB #1 on April 06, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202361
- Company Name: Gundersen Clinic Ltd, IRB #1
- Inspection Date: 2023-04-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1202361 - 2023-04-06](https://www.keypedia.com/records/fda_inspections/gundersen-clinic-ltd-irb-1/7bfda537-4067-47b7-819a-901b867d4de8)
- [FDA Inspection 986163 - 2016-09-07](https://www.keypedia.com/records/fda_inspections/gundersen-clinic-ltd-irb-1/d3361065-3b99-41cb-a54f-a770b2741bc6)
- [FDA Inspection 747974 - 2011-09-29](https://www.keypedia.com/records/fda_inspections/gundersen-clinic-ltd-irb-1/b22e9569-d756-46cc-904e-878a779cb3f0)

Company: https://www.keypedia.com/companies/gundersen-clinic-ltd-irb-1/b2d34d52-8c50-4819-8e69-45205d08e314

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c